Rezolute (RZLT) Total Current Liabilities (2011 - 2026)
Rezolute's (RZLT) quarterly Total Current Liabilities came in at $7.7 million in Q1 2026, down 26.82% year-on-year from $10.5 million in Q1 2025, and down 18.91% quarter-over-quarter from $9.5 million in Q4 2025.
Rezolute (RZLT) Total Current Liabilities (2011 - 2026) Analysis & Trends
Rezolute has disclosed Total Current Liabilities across 16 years of filings, most recently posting $7.7 million for Q1 2026.
- Total Current Liabilities for Q1 2026 came in at $7.7 million, down 26.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.7 million (down 26.82% YoY), and the FY2025 annual result was $11.9 million, up 24.01% from the prior year.
- Total Current Liabilities came in at $7.7 million for Q1 2026 at Rezolute, down from $9.5 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $11.9 million in Q2 2025 to a low of $2.4 million in Q3 2022.
- The 5-year median for Total Current Liabilities is $7.7 million (2026), against an average of $7.3 million.
- Across the five-year window, Total Current Liabilities soared 196.42% in 2023 and decreased 26.82% in 2026, its largest moves.
- Rezolute's Total Current Liabilities stood at $6.3 million in 2022, then rose by 27.11% to $8.0 million in 2023, then soared by 32.47% to $10.6 million in 2024, then dropped by 10.44% to $9.5 million in 2025, then slipped by 18.91% to $7.7 million in 2026.
- The last three Total Current Liabilities figures came in at $7.7 million (Q1 2026), $9.5 million (Q4 2025), and $10.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.70 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 636.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 13.42 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 3.88 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 72.86 Mn |
| 10 | Rezolute | 520.13 Mn | 520.13 Mn | - | 7.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.70 Mn |
| Dec 31, 2025 | 9.50 Mn |
| Sep 30, 2025 | 10.21 Mn |
| Jun 30, 2025 | 11.91 Mn |
| Mar 31, 2025 | 10.53 Mn |
| Dec 31, 2024 | 10.61 Mn |
| Sep 30, 2024 | 8.00 Mn |
| Jun 30, 2024 | 9.61 Mn |
| Mar 31, 2024 | 6.96 Mn |
| Dec 31, 2023 | 8.01 Mn |
| Sep 30, 2023 | 7.20 Mn |
| Jun 30, 2023 | 5.20 Mn |
| Mar 31, 2023 | 4.40 Mn |
| Dec 31, 2022 | 6.30 Mn |
| Sep 30, 2022 | 2.43 Mn |
| Jun 30, 2022 | 2.46 Mn |
| Mar 31, 2022 | 2.90 Mn |
| Dec 31, 2021 | 6.40 Mn |
| Sep 30, 2021 | 2.60 Mn |
| Jun 30, 2021 | 1.97 Mn |